The "love hormone" — endogenous bonding peptide also prescribed as Pitocin for labor induction, and used off-label for social connection, orgasm intensity, and mood.
Oxytocin is a nine-amino-acid neuropeptide produced in the hypothalamus and released by the posterior pituitary. It governs uterine contraction during labor, milk ejection during breastfeeding, and — most relevantly for peptide therapy use — social bonding, trust, empathy, and orgasm.
The FDA-approved pharmaceutical form, Pitocin, is used for labor induction and postpartum hemorrhage control. Off-label use for social / sexual / mood applications typically involves intranasal delivery (crosses the blood-brain barrier better than injection) or SubQ.
Pharmaceutical oxytocin (Pitocin) FDA approved for specific indications. Not WADA prohibited. Off-label / research-peptide use is common.
Binds oxytocin receptors in the brain (hypothalamus, amygdala, nucleus accumbens) and peripheral tissues. Central effects drive the bonding / trust / empathy changes; peripheral drives contraction.
Oxytocin doesn’t cross the blood-brain barrier well from the bloodstream, so injections produce peripheral effects without much central effect. Intranasal delivery bypasses the BBB via olfactory and trigeminal nerve pathways — most research on "oxytocin for bonding" uses intranasal.
Plasma half-life ~3–5 minutes. Effects from a dose are functionally ~30–60 min in CNS depending on delivery route.
| Benefit | Evidence |
|---|---|
| Labor induction (Pitocin) | Gold-standard clinical use; FDA approved |
| Social bonding / trust | Classic Kosfeld 2005 Nature study and follow-ups; effects are real but modest |
| Orgasm intensity | Intranasal before sexual activity reported to enhance orgasm; small studies |
| Autism spectrum | Mixed trials for social communication improvement; SOARS-B Phase 2 was negative; smaller studies more positive |
| Breastfeeding support | Nasal spray commonly prescribed for milk letdown difficulty |
| Anxiety / depression | Mixed but intriguing; studied in social anxiety disorder |
Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.
Start Tracking FreeSubQ produces mainly peripheral effects; for central bonding / mood effects, intranasal is preferred.
Research-chem oxytocin is often supplied as milligrams; pharmaceutical forms use IU. Typical conversion: 1 mg = ~500 IU of oxytocin activity. Always confirm your specific product’s concentration.
2 mg vial + 5 mL saline = 400 mcg/mL (~200 IU/mL). Standard pump delivers ~100 µL (0.1 mL) = 40 mcg per spray (~20 IU). 1–2 sprays for typical dose.
Pre-filled with a typical Oxytocin setup. Edit any field — the draw updates live.
Insulin syringe — 100 units = 1 mL
Free account. Saves your reconstitution + schedules doses + tracks every vial.
Dosing cheat sheet, reconstitution reference, and cycle planning — delivered to your inbox.
Oxytocin is a research peptide not approved by the FDA for human use. It is sold only as a research chemical, and StackTrax does not endorse or facilitate personal use.
Quality varies enormously among research-chemical suppliers. At minimum, look for:
StackTrax’s preferred partner NextGen Peptides does not currently carry Oxytocinin their catalog, which is why you don’t see a direct purchase link here. Other major research-chemical suppliers carry it; we don’t specifically recommend one for this compound.
Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.
Start Tracking FreeYes, but only as Pitocin for specific obstetric indications: labor induction and postpartum hemorrhage control. Off-label use for social bonding, sexual, or mood applications is not FDA approved and typically involves intranasal delivery or subcutaneous injection through compounding pharmacies or the research-chemical market. Oxytocin is not WADA prohibited.
Oxytocin does not cross the blood-brain barrier well from the bloodstream, so injections produce peripheral effects (uterine contraction, milk ejection) without much central effect. Intranasal delivery bypasses the BBB via olfactory and trigeminal nerve pathways, which is why most research on oxytocin for bonding, trust, and empathy uses the intranasal route. Subcutaneous dosing mainly produces peripheral effects.
The Kosfeld 2005 Nature study and follow-ups show real but modest effects on social bonding and trust. Intranasal oxytocin before sexual activity has also been reported to enhance orgasm in small studies. Effects are not dramatic and oxytocin can intensify current mood in either direction, not just positive.
The evidence is mixed. The SOARS-B Phase 2 trial was negative for social communication improvement in autism spectrum disorder, while smaller studies have been more positive. Mixed results overall, with no clear consensus on whether intranasal oxytocin produces clinically meaningful benefit in this population.
Intranasal is the most common off-label route at 10 to 40 IU (roughly 20 to 80 mcg), PRN or once daily, 30 to 45 minutes before the desired effect. Subcutaneous dosing is 2 to 10 IU, but this mainly produces peripheral effects. The plasma half-life is about 3 to 5 minutes, with functional CNS effects lasting roughly 30 to 60 minutes depending on route.
Common mild effects include nasal irritation (intranasal), mild headache, transient nausea, and mood changes that are not always positive since oxytocin can intensify current mood in either direction. Less common effects include water retention at higher doses (antidiuretic effect), flushing, and mild blood pressure increases.
Do not use oxytocin in pregnancy (unless under obstetric care for labor induction), with hyponatremia risk from excess water intake, or with known hypersensitivity to oxytocin. Use caution with cardiovascular disease, uncontrolled blood pressure, and psychiatric conditions where mood intensification could be harmful.
Disclaimer: This guide is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. The compounds discussed are not FDA approved for human use. Always consult a qualified healthcare provider before starting any new supplement or peptide protocol. StackTrax does not sell peptides or supplements directly — purchase links go to third-party vendors. StackTrax is not responsible for the products, quality, or business practices of any third-party vendor. This page contains affiliate links — StackTrax may earn a commission on purchases at no extra cost to you.
© 2026 StackTrax, LLC. All rights reserved.
StackTrax guides cover peptides and compounds that are not FDA-approved for the uses discussed. The dosing, reconstitution, and safety information is compiled from published research and community protocols for educational purposes only.
Before using any compound mentioned here, consult a qualified healthcare provider. StackTrax does not sell, prescribe, or recommend these substances for personal use.
These pages also contain affiliate links. We may earn a commission on purchases at no extra cost to you — this never changes our editorial recommendations.